Type 2 diabetes trials in South Korea

In South Korea 64 Also abroad 1196

64 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.

Phase 3RecruitingTrial-stage medicine
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Where
Bucheon-si, Gyeonggi-do, Jongno-gu, Junggu, Seoul
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07664553EU 2025-523935-20-00Registry updated 2026-08-04
Phase 4RecruitingTrial-stage medicine
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Where
Seongnam-si
Age
19 years and over
People
1,200
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT07719894Registry updated 2026-07-22
No phaseEnrolling by invitationResearch participation
Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
Where
Seoul
Age
19 years and over
People
800,000
Run by
Novo Nordisk A/S
See details and how to joinNCT07673822Registry updated 2026-06-29
Phase 3Not yet recruitingTrial-stage medicine
To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus
Where
Seoul
Age
18 years to 80 years
People
510
Run by
Daewoong Pharmaceutical Co. LTD.
See details and how to joinNCT07619833Registry updated 2026-06-02
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Where
Gyeonggi-do
Age
19 years and over
People
118
Run by
Hanmi Pharmaceutical Company Limited
See details and how to joinNCT07379333Registry updated 2026-05-13
Phase 4RecruitingTrial-stage medicine
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Where
Seongnam-si
Age
20 years and over
People
56
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT05365425Registry updated 2026-05-05
Phase 4RecruitingTrial-stage medicine
Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Where
Seongnam-si
Age
20 years to 80 years
People
105
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT05365438Registry updated 2026-05-05
No phaseEnrolling by invitationResearch participation
Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Where
Jeonlabuk-do
Age
19 years and over
People
600
Run by
Novo Nordisk A/S
See details and how to joinNCT05689372Registry updated 2026-05-05
Phase 4RecruitingTrial-stage medicine
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
Where
Seongnam-si
Age
20 years to 80 years
People
120
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT06399835Registry updated 2026-05-05
Phase 4RecruitingTrial-stage medicine
Clopidogrel Versus Cilostazol on Vessels
Where
Seongnam-si
Age
19 years and over
People
120
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT06402747Registry updated 2026-05-05
Phase 3RecruitingTrial-stage medicine
Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus
Where
Seoul
Age
19 years and over
People
228
Run by
Hanlim Pharm. Co., Ltd.
See details and how to joinNCT07552389Registry updated 2026-04-27
Phase 2RecruitingTrial-stage medicine
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Busan, Goyang-si, Gyeonggi-do, Seoul
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698EU 2024-510846-15-00Registry updated 2026-03-11
No phaseRecruitingTrial-stage medicine
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
Where
Seoul
Age
70 years and over
People
2,186
Run by
Sin Gon Kim
See details and how to joinNCT07359105Registry updated 2026-03-10
Phase 4RecruitingTrial-stage medicine
Glycemic Variability of Combination Therapies in T2DM
Where
Seoul
Age
19 years and over
People
178
Run by
JW Pharmaceutical
See details and how to joinNCT07442006Registry updated 2026-03-02
Phase 4Not yet recruitingTrial-stage medicine
Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
Where
Seoul
Age
19 years and over
People
200
Run by
Chong Kun Dang Pharmaceutical
See details and how to joinNCT07365358Registry updated 2026-01-26
Phase 3RecruitingTrial-stage medicine
Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Where
Anyang, Buchon, Busan, Cheonan, Daegu, Daejeon, Goyang-si, Guri-si, Gwangju, Iksan, Inchon, Jeonju, Seongnam, Seoul, Suwon, Wŏnju, Yongin-si
Age
19 years to 80 years
People
240
Run by
CMG Pharmaceutical Co. Ltd
See details and how to joinNCT06772168Registry updated 2026-01-15
No phaseRecruitingResearch participation
Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use
Where
Seoul
Age
19 years to 80 years
People
150
Run by
Kangbuk Samsung Hospital
See details and how to joinNCT07336329Registry updated 2026-01-13
Phase 2Not yet recruitingTrial-stage medicine
Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Where
Seoul
Age
19 years and over
People
288
Run by
Dong-A ST Co., Ltd.
See details and how to joinNCT07239440Registry updated 2025-11-20
No phaseRecruitingResearch participation
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Where
Incheon
Age
19 years and over
People
9,000
Run by
Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT05970237Registry updated 2025-09-15
Phase 4RecruitingTrial-stage medicine
A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes
Where
Seoul
Age
19 years and over
People
204
Run by
Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06972732Registry updated 2025-09-15
Phase 4RecruitingTrial-stage medicine
Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
Where
Seoul
Age
20 years to 79 years
People
30
Run by
Korea University Anam Hospital
See details and how to joinNCT06782139Registry updated 2025-09-02
Phase 3RecruitingTrial-stage medicine
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
Where
Seoul
Age
19 years and over
People
171
Run by
Celltrion
See details and how to joinNCT07093476Registry updated 2025-08-11
Phase 4Not yet recruitingTrial-stage medicine
Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors
Where
Seoul
Age
19 years to 75 years
People
100
Run by
Yonsei University
See details and how to joinNCT07108985Registry updated 2025-08-07
No phaseNot yet recruitingResearch participation
A Study of DIA:CONN P8 Smart Insulin Pen With CGM-Based Coaching in Patients With Type 1 or Type 2 Diabetes
Where
Seoul
Age
19 years to 75 years
People
152
Run by
G2e Co., Ltd
See details and how to joinNCT07004153Registry updated 2025-06-04
Phase 3RecruitingTrial-stage medicine
Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes
Where
Seongnam-si
Age
60 years and over
People
80
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT06989697Registry updated 2025-05-25

All Type 2 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error